91 related articles for article (PubMed ID: 19912340)
21. Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha.
Cascio S; Bartella V; Auriemma A; Johannes GJ; Russo A; Giordano A; Surmacz E
Oncogene; 2008 Jan; 27(4):540-7. PubMed ID: 17653093
[TBL] [Abstract][Full Text] [Related]
22. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.
Catrina SB; Botusan IR; Rantanen A; Catrina AI; Pyakurel P; Savu O; Axelson M; Biberfeld P; Poellinger L; Brismar K
Clin Cancer Res; 2006 Aug; 12(15):4506-14. PubMed ID: 16899596
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.
Buchholz B; Schley G; Faria D; Kroening S; Willam C; Schreiber R; Klanke B; Burzlaff N; Jantsch J; Kunzelmann K; Eckardt KU
J Am Soc Nephrol; 2014 Mar; 25(3):465-74. PubMed ID: 24203996
[TBL] [Abstract][Full Text] [Related]
25. Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells.
Milosevic J; Adler I; Manaenko A; Schwarz SC; Walkinshaw G; Arend M; Flippin LA; Storch A; Schwarz J
Neurotox Res; 2009 May; 15(4):367-80. PubMed ID: 19384570
[TBL] [Abstract][Full Text] [Related]
26. Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.
Cook KM; Hilton ST; Mecinovic J; Motherwell WB; Figg WD; Schofield CJ
J Biol Chem; 2009 Sep; 284(39):26831-8. PubMed ID: 19589782
[TBL] [Abstract][Full Text] [Related]
27. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells.
Staab A; Loeffler J; Said HM; Diehlmann D; Katzer A; Beyer M; Fleischer M; Schwab F; Baier K; Einsele H; Flentje M; Vordermark D
BMC Cancer; 2007 Nov; 7():213. PubMed ID: 17999771
[TBL] [Abstract][Full Text] [Related]
28. Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane.
Itoh T; Namba T; Fukuda K; Semenza GL; Hirota K
FEBS Lett; 2001 Dec; 509(2):225-9. PubMed ID: 11741593
[TBL] [Abstract][Full Text] [Related]
29. The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia.
Ding XC; Wang LL; Zhang XD; Xu JL; Li PF; Liang H; Zhang XB; Xie L; Zhou ZH; Yang J; Weichselbaum RR; Yu JM; Hu M
J Hematol Oncol; 2021 Jun; 14(1):92. PubMed ID: 34118979
[TBL] [Abstract][Full Text] [Related]
30. Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells.
Huang XJ; Ma ZQ; Zhang WP; Lu YB; Wei EQ
J Pharm Pharmacol; 2007 Jun; 59(6):849-56. PubMed ID: 17637177
[TBL] [Abstract][Full Text] [Related]
31. Loss of cell-matrix contact increases hypoxia-inducible factor-dependent transcriptional activity in glioma cells.
Maurer GD; Brucker DP; Steinbach JP
Biochem Biophys Res Commun; 2019 Jul; 515(1):77-84. PubMed ID: 31128911
[TBL] [Abstract][Full Text] [Related]
32. Chetomin, a Hsp90/HIF1α pathway inhibitor, effectively targets lung cancer stem cells and non-stem cells.
Min S; Wang X; Du Q; Gong H; Yang Y; Wang T; Wu N; Liu X; Li W; Zhao C; Shen Y; Chen Y; Wang X
Cancer Biol Ther; 2020 Aug; 21(8):698-708. PubMed ID: 32489150
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate alpha-helix.
Henchey LK; Kushal S; Dubey R; Chapman RN; Olenyuk BZ; Arora PS
J Am Chem Soc; 2010 Jan; 132(3):941-3. PubMed ID: 20041650
[TBL] [Abstract][Full Text] [Related]
34. Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.
Lo Dico A; Valtorta S; Martelli C; Belloli S; Gianelli U; Tosi D; Bosari S; Degrassi A; Russo M; Raccagni I; Lucignani G; Moresco RM; Ottobrini L
Mol Imaging Biol; 2014 Apr; 16(2):210-23. PubMed ID: 24002614
[TBL] [Abstract][Full Text] [Related]
35. Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma.
Oh J; Kim Y; Che L; Kim JB; Chang GE; Cheong E; Kang SG; Ha Y
PLoS One; 2017; 12(11):e0178881. PubMed ID: 29161257
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of hypoxia-inducible factor-1α in buffer containing cobalt chloride for Western blot analysis.
Srinivasan S; Dunn JF
Anal Biochem; 2011 Sep; 416(1):120-2. PubMed ID: 21601556
[TBL] [Abstract][Full Text] [Related]
37. Myricetin alleviates the formaldehyde-enhanced Warburg effect in tumor cells through inhibition of HIF-1α.
Li L; Ma H; Li D; Shu Q; Wang T; Song X; Xu H
Toxicol Appl Pharmacol; 2022 Nov; 454():116246. PubMed ID: 36116563
[TBL] [Abstract][Full Text] [Related]
38. Trefoil factor 3 contributes to the malignancy of glioma via regulating HIF-1α.
Diao S; Zheng Q; Gao J; Yao Y; Ren S; Liu Y; Xu Y
Oncotarget; 2017 Sep; 8(44):76770-76782. PubMed ID: 29100347
[TBL] [Abstract][Full Text] [Related]
39. Microarray analysis of the hypoxia-induced gene expression profile in malignant C6 glioma cells.
Huang XD; Wang ZF; Dai LM; Li ZQ
Asian Pac J Cancer Prev; 2012; 13(9):4793-9. PubMed ID: 23167422
[TBL] [Abstract][Full Text] [Related]
40. Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.
He T; Smith N; Saunders D; Pittman BP; Lerner M; Lightfoot S; Silasi-Mansat R; Lupu F; Towner RA
Am J Nucl Med Mol Imaging; 2013; 3(4):300-11. PubMed ID: 23901356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
